Concepedia

Ruihong Dai

RD

4

Publications

231

Citations

4

H-Index

2004

Active since

Affiliations

Sichuan Cancer Hospital(Current)

Shandong Tumor Hospital

Shandong First Medical University

Sichuan University

Anhui Provincial Hospital

Ruihong Dai is an author at Sichuan Cancer Hospital specializing in medicine, oxidative stress, and tumor biology.

ORCID

Top concepts

Publications per year

2004–2025

4

Publications

4

Angiogenesis and anti-angiogenesis activity of Chinese medicinal herbal extracts

Shanshan Wang, Zhengui Zheng, Yinqi Weng et al. · Life Sciences · 2004 · 191 citations

, , +4

Safety and preliminary efficacy results of IBI389, an anti-CLDN18.2/CD3 bispecific antibody, in patients with solid tumors and gastric or gastro-esophageal tumors: A phase 1 dose escalation and expansion study.

Zheng Li, Ruihong Dai, Jieer Ying et al. · Journal of Clinical Oncology · 2024 · 15 citations

Safety and efficacy of IBI389, an anti-CLDN18.2/CD3 bispecific antibody, in patients with advanced pancreatic ductal adenocarcinoma: Preliminary results from a phase 1 study.

Jihui Hao, Zheng Li, Ruihong Dai et al. · Journal of Clinical Oncology · 2024 · 14 citations

, , +20

Engineering porous Beta zeolite-encapsulated nickel catalyst for waste polyolefins upcycling

Jiahui Zhan, Lin Li, Ruihong Dai et al. · Applied Catalysis B: Environmental · 2025 · 11 citations · Full text

Rows per page

1–4 of 4